Google
PROF — PROFOUND MEDICAL CORP (Healthcare >> Medical Devices)
PROF FAQ
What is PROF's ROE?
PROFOUND MEDICAL CORP reports a Return on Equity (ROE) of -65.74%.
What is PROF's dividend yield?
PROFOUND MEDICAL CORP offers a dividend yield of 0.00%.
What is PROF's Deepscope Quality Score?
Deepscope rates PROF's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy PROF?
Deepscope's AI Timing Score for PROF is 55 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does PROF belong to?
PROFOUND MEDICAL CORP is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange.
|
USD 6.66
Price
-0.13
(-1.91%)
Day Change
|
|
|---|
PROF, the overall quality is not good ( Quality = 23) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 82 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 6.66 |
| PBV / Sector |
4.14 / 7.50
|
| Earning Per Share | -1.06 |
| PE / Sector |
N/A / 29.01
|
| PEG or PE/Growth / Sector |
N/A / 0.39
|
| Average 1M Daily Value |
0.49 M
GREAT
|
| Average 1W Daily Value |
0.54 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
50% |
| Ability to Make Profit |
|
56% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-06 09:09:07 |
| Symbol | PROF |
| Name | PROFOUND MEDICAL CORP |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 36.34 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 246.73 / 18,389.26 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 2400 Skymark Avenue, Mississauga, ON, Canada, L4W 5K5
Phone: 647 476 1350
Website: https://www.profoundmedical.com
Employees: 162
Sector: Healthcare >> Medical Devices
Description: Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
